Skip to search.
 TSX Up 0.06% TSX Ventures Up 0.46%

Regulus Therapeutics Inc. (RGLS)

-NasdaqGM
3.24 Up 0.08(2.53%) Aug 26, 4:00PM EDT
Prev Close:3.16
Open:3.16
Bid:3.21 x 100
Ask:3.38 x 200
1y Target Est:10.20
Beta:1.90452
Earnings Date:Nov 3 - Nov 7 (Est.)
Day's Range:3.09 - 3.27
52wk Range:2.44 - 10.60
Volume:291,182
Avg Vol (3m):811,673
Market Cap:171.14M
P/E (ttm):N/A
EPS (ttm):-1.19
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):12.19
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-16) :-1.59
Quarterly EPS Est (Sep-16) :-0.40
Mean Recommendation*:1.6
PEG Ratio (5 yr expected):-0.05

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Regulus Therapeutics Inc., a biopharmaceutical company, focuses on the discovery and development of drugs that target RNAs to treat a range of diseases in the United States. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback